Low RSV Vaccination Rates Among Older Adults: A Study Analysis

A recent study published in Vaccine has highlighted that RSV vaccination rates among older adults in the U.S. remained relatively low during the 2024–25 respiratory virus season. The Advisory Committee on Immunization Practices recommended that adults aged 60 to 74 at higher risk of severe RSV and all adults aged 75 and older should receive the vaccine. Analysis by the Centers for Disease Control and Prevention (CDC) revealed that 38.3% of higher-risk adults aged 60 to 74 and 41.5% of those aged 75 and older were vaccinated against RSV by the end of the respiratory season.

Vaccination rates showed significant geographic and demographic variability. Coverage ranged from approximately 10% to 60% across different states and territories, generally higher among individuals with more income, greater education, and without disabilities. Those with health insurance and those who were advised by healthcare providers exhibited higher vaccination rates. Moreover, individuals concerned about contracting RSV and those who trusted the vaccine's safety were more likely to get vaccinated. White adults had higher vaccination rates compared to Black and Hispanic adults.

The study suggests that increasing outreach from healthcare providers, addressing access barriers, and engaging with community-based organizations and trusted public health entities could enhance confidence and improve vaccination rates.

COVID-19 Vaccination and Long COVID Risk in Cancer Patients

In related news, a study in JAMA Network Open highlighted COVID-19 vaccinations' role in reducing the risk of long COVID among cancer patients during the Omicron wave. Conducted in Singapore, the retrospective study involved over 76,000 cancer patients, most of whom had received booster doses. The analysis did not find a significant difference in the risk of long COVID between infected and non-infected cancer patients, although those hospitalized with COVID-19 had a higher risk compared to those hospitalized with the flu.

Mpox Cases and Public Health Response in Berlin

Furthermore, a rapidly increasing cluster of mpox cases in Berlin, primarily among men who have sex with men, has been identified, pointing to a shift from travel-related infections to local transmissions. Genetic analysis suggests the cases are related, indicating a shared transmission network. This development underscores the need for robust testing, vaccination efforts, and genomic surveillance to control the spread.

The CDC is also urged to fill its Senate-confirmed positions promptly within the legally mandated period to maintain effective leadership and regulatory oversight. The study findings and evolving health data continue to shape vaccine strategy and public health policies moving forward.